CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting.
Chronic myelomonocytic leukemia (CMML) is a rare blood cancer of older adults (3 in every 1,000,000 persons) characterized by poor survival and lacking effective mutation-specific therapy. Mutations in the ubiquitin ligase Cbl occur frequently in CMML and share biological and molecular features with...
Saved in:
| Main Authors: | Kelly Lim, Winnie L Kan, Pramod C Nair, Monika Kutyna, Angel F Lopez, Timothy Hercus, David M Ross, Steven Lane, Chun Yew Fong, Anna Brown, Agnes Yong, David Yeung, Timothy Hughes, Devendra Hiwase, Daniel Thomas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0310641 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preparation of chimeric genes without subcloning
by: Jozica Vasl, et al.
Published: (2004-11-01) -
Subclonal response heterogeneity to define cancer organoid therapeutic sensitivity
by: Jeremy D. Kratz, et al.
Published: (2025-04-01) -
Advances in tumor subclone formation and mechanisms of growth and invasion
by: Yuhong Zhang, et al.
Published: (2025-04-01) -
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor Phenotype
by: Viktoria Chirico, et al.
Published: (2025-08-01) -
Resolving spatial subclonal genomic heterogeneity of loss of heterozygosity and extrachromosomal DNA in gliomas
by: Michelle G. Webb, et al.
Published: (2025-06-01)